These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29338136)

  • 21. The effect of mid-luteal estradiol level on the outcome of ICSI-ET cycles.
    Aktan E; Bozkurt K; Ozer D; Yucebilgin S; Karadadas N; Bilgin O
    Arch Gynecol Obstet; 2004 Jan; 269(2):134-8. PubMed ID: 12928936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection.
    Bergh C; Lindenberg S;
    Hum Reprod; 2012 Dec; 27(12):3467-73. PubMed ID: 23019296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
    Balasch J; Creus M; Fábregues F; Carmona F; Casamitjana R; Peñarrubia J; Rivera F; Vanrell JA
    Gynecol Endocrinol; 1995 Mar; 9(1):51-8. PubMed ID: 7793300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection cycles: a systematic review and meta-analysis.
    Gelbaya TA; Kyrgiou M; Tsoumpou I; Nardo LG
    Fertil Steril; 2008 Dec; 90(6):2116-25. PubMed ID: 18178194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial.
    Fatemi HM; Kolibianakis EM; Camus M; Tournaye H; Donoso P; Papanikolaou E; Devroey P
    Hum Reprod; 2006 Oct; 21(10):2628-32. PubMed ID: 16857887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone.
    Romàn E; Aytoz A; Smitz JE; Faguer B; Camus M; Van Steirteghem AC; Devroey P
    Hum Reprod; 2000 Jul; 15(7):1435-9. PubMed ID: 10875847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P; Domingo M; Leader A
    Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should progesterone on the human chorionic gonadotropin day still be measured?
    Martinez F; Rodriguez I; Devesa M; Buxaderas R; Gómez MJ; Coroleu B
    Fertil Steril; 2016 Jan; 105(1):86-92. PubMed ID: 26453983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol.
    Fatemi HM; Camus M; Kolibianakis EM; Tournaye H; Papanikolaou EG; Donoso P; Devroey P
    Fertil Steril; 2007 Mar; 87(3):504-8. PubMed ID: 17140572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
    Tournaye H; Sukhikh GT; Kahler E; Griesinger G
    Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome.
    Sharara FI; McClamrock HD
    Hum Reprod; 1999 Nov; 14(11):2777-82. PubMed ID: 10548621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a single injection of human chorionic gonadotropin at peak follicular maturation in natural cycles on pregnancy rate and mid-luteal hormonal and sonographic parameters.
    Check JH; Liss JR; DiAntonio G; Summers D
    Clin Exp Obstet Gynecol; 2016; 43(3):328-9. PubMed ID: 27328483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles.
    Mochtar MH; Van Wely M; Van der Veen F
    Hum Reprod; 2006 Apr; 21(4):905-8. PubMed ID: 16373409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
    Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
    Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles--but only in younger women.
    Gleicher N; Brown T; Dudkiewicz A; Karande V; Rao R; Balin M; Campbell D; Pratt D
    Early Pregnancy (Cherry Hill); 2000 Jan; 4(1):64-73. PubMed ID: 11719823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral oestradiol supplementation as luteal support in IVF/ICSI cycles: a prospective, randomized controlled study.
    Lin H; Li Y; Li L; Wang W; Zhang Q; Chen X; Yang D
    Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):171-5. PubMed ID: 23287635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Embryo transfer and luteal support in natural cycles.
    Vlaisavljevic V
    Reprod Biomed Online; 2007 Jun; 14(6):686-92. PubMed ID: 17579979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.